| 50881-044-08 |
50881-044 |
HUMAN PRESCRIPTION DRUG |
JAKAFI XR |
ruxolitinib |
TABLET, EXTENDED RELEASE |
ORAL |
20260501 |
N/A |
NDA |
NDA217180 |
Incyte Corporation |
RUXOLITINIB |
44 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-044-08) |
| 50881-022-08 |
50881-022 |
HUMAN PRESCRIPTION DRUG |
JAKAFI XR |
ruxolitinib |
TABLET, EXTENDED RELEASE |
ORAL |
20260501 |
N/A |
NDA |
NDA217180 |
Incyte Corporation |
RUXOLITINIB |
22 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-022-08) |
| 50881-033-08 |
50881-033 |
HUMAN PRESCRIPTION DRUG |
JAKAFI XR |
ruxolitinib |
TABLET, EXTENDED RELEASE |
ORAL |
20260501 |
N/A |
NDA |
NDA217180 |
Incyte Corporation |
RUXOLITINIB |
33 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-033-08) |
| 50881-011-08 |
50881-011 |
HUMAN PRESCRIPTION DRUG |
JAKAFI XR |
ruxolitinib |
TABLET, EXTENDED RELEASE |
ORAL |
20260501 |
N/A |
NDA |
NDA217180 |
Incyte Corporation |
RUXOLITINIB |
11 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-011-08) |
| 50881-055-08 |
50881-055 |
HUMAN PRESCRIPTION DRUG |
JAKAFI XR |
ruxolitinib |
TABLET, EXTENDED RELEASE |
ORAL |
20260501 |
N/A |
NDA |
NDA217180 |
Incyte Corporation |
RUXOLITINIB |
55 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-055-08) |